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Background: To determine the validity of a semi-automated segmentation of bone marrow lesions (BMLs) in the knee.
Methods: Construct validity of the semi-automated BML segmentation method was explored in two studies
performed using sagittal intermediate weighted, turbo spine echo, fat-suppressed magnetic resonance imaging
sequences obtained from the Osteoarthritis Initiative. The first study (n = 48) evaluated whether tibia BML volume
was different across Boston Leeds Osteoarthritis Knee Scores (BLOKS) for tibia BMLs (semiquantitative grades 0 to 3).
In the second study (n = 40), we evaluated whether BML volume change was associated with changes in cartilage
parameters. The knees in both studies were segmented by one investigator. We performed Wilcoxon signed-rank
tests to determine if tibia BML volume was different between adjacent BLOKS BML scores and calculated Spearman
correlation coefficients to assess the relationship between 2-year BML volume change and 2-year cartilage
morphometry change (significance was p ≤ 0.05).
Results: BML volume was significantly greater between BLOKS BML score 0 and 1 (z = 2.85, p = 0.004) and
BLOKS BML scores 1 and 2 (z = 3.09, p = 0.002). There was no significant difference between BLOKS BML scores 2
and 3 (z = −0.30, p = 0.77). Increased tibia BML volume was significantly related to increased tibia denuded area
(Spearman r = 0.42, p = 0.008), decreased tibia cartilage thickness (Spearman r = −0.46, p = 0.004), increased femur
denuded area (Spearman r = 0.35, p = 0.03), and possibly decreased femur cartilage thickness (Spearman r = −0.30,
p = 0.07) but this last finding was not statistically significant.
Conclusion: The new, efficient, and reliable semi-automated BML segmentation method provides valid BML
volume measurements that increase with greater BLOKS BML scores and confirms previous reports that BML size is
associated with longitudinal cartilage loss.
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Periarticular bone changes are integral to knee osteo-
arthritis (OA) progression [1-6]. More specifically, bone
marrow lesions (BMLs), common magnetic resonance
(MR) imaging findings in joints with OA, are related to OA
progression and pain [1-7]. In fat suppressed MR images,
BMLs are characterized as areas of high-signal intensity
within bone [8,9]. Several methods can assess BML size in
knees including semi-quantitative scoring [8,10], approxi-
mating BML size based on linear measurements [5,6,11,12],
or manual/semi-automated segmentation [13-17].
While the current techniques have clarified the clinical
relevance of BMLs in OA progression they may be
limited by a lack of sensitivity to change, a dependence
on the reader to identify BMLs, or the amount of time
required to quantify BML size. One simple approach to
measure BML size is to measure the greatest cross-
sectional diameter of a BML [5]. This method is time-
efficient and offers a quantitative outcome; however,
only one dimension is under scrutiny; therefore, other
changes may occur that go unnoticed. On the other
hand, three-dimensional measurements, based on three
cross-sectional measures [6,11,12], are a time efficient
method to assess BMLs with good construct validity but
include a lot of healthy bone. The most accurate method
to assess BML size may be detailed image or volumetric
segmentation [13,14] but to date accurate results require
substantial user interaction and thus requires an extensive
amount of time to complete. For example, semi-automated
segmentation methods often use manual steps that may
introduce measurement error or increase the burden on
the assessor (e.g., manually delineating regions of interest,
manually marking areas of health bone) [16,17]. Ideally, a
new quantitative BML measurement would be accurate
and time efficient.
The purpose of this study was to determine the validity
of a new semi-automated BML segmentation method. We
hypothesize that this new measure of BML size will
increase with greater semi-quantitative scores and relate to
articular cartilage loss (construct validity). This approach
not only reduces the time involved in segmentation, but
can also easily be deployed by researchers.
Methods
To assess the validity of the new semi-automated BML
segmentation method we conducted two analyses using
images and data obtained from the Osteoarthritis Initiative
(OAI) databases, which are available for public access at
http://oai.epi-ucsf.org. The OAI is a multi-center observa-
tional cohort study of knee OA that collected longitudinal
clinical and image data [18] as well as biospecimens over a
nine year period. All BML measurements were performed
using sagittal intermediate weighted, turbo spine echo, fat-
suppressed MR sequences (field of view = 160 mm, slicethickness = 3 mm, skip = 0 mm, flip angle = 180 degrees,
echo time = 30 ms, recovery time = 3200 ms, 313 X 448
matrix [interpolated to 512 X 512], phase encode superior/
inferior. x resolution = 0.357 mm, and y resolution =
0.511 mm). All images were obtained using one of four
identical Siemens Trio 3 T MR systems and a USA Instru-
ments quadrature transmit-receive knee coil at one of four
OAI clinical sites.
Semi-automated BML segmentation
The new semi-automated segmentation method detects,
extracts, and quantifies the structure of BMLs in three
major steps: bone segmentation, BML segmentation, and
BML quantification. In the first step, boundaries of tibia
and femur were identified using a process scheme that is
automatic except for some coarse initialization provided
by the user. The second, fully automated step segmented
BMLs within the tibia and femur regions identified from
the first step. The third step which is also fully auto-
mated eliminated some false positive regions identified
in the previous step and calculated the BML volumes.
In the first step we used a custom graphical user interface
(GUI; MATLAB, MathWorks, Inc., Natick, MA, USA) to
manually identify the boundaries of the tibia and femur in
each slice of the MR imaging data set by marking multiple
points along the articular surface (see Figure 1a). For the
border furthest from the articular surface the rater either
marked the bone just prior to the epiphyseal line or at the
edge of bone and soft tissue (images near the medial or lat-
eral sides of the knee; Figure 1b). In addition, we omitted
the central slices from the analyses (i.e., the middle 9 slices;
2.7 cm) to focus on BMLs adjacent to the tibiofemoral
chondral surface and to improve reliability. Excluding these
images improved reliability because the segmentation
method was inconsistent at defining the border of the bone
and there was increased signal-intensity heterogeneity
within the bone. Manually marking the bone, the only part
of this processing stage involving user interaction, required
8 to 24 min per pair of MR image sets (one knee at two
time points) compared to approximately 30 to 45 min per
pair of MR image sets using cross-sectional measurements
to approximate BML volume [6]. After the tibia and femur
boundaries were marked we used an edge-based curve
evolution technique [19] to refine the initial estimate to
more precisely identify the bone boundaries. An edge-
based curve evolution technique [19] was considered
optimal because bone typically has well defined boundaries.
This process of refinement does not require the initial
curves to be immediately adjacent to the bone boundaries
(Figure 1a and c) [19].
The second step, BML segmentation, automatically
identified the boundaries of the BMLs within the bone
region found in the first step by using a region-based
curve evolution algorithm [20], which was considered an
Figure 1 Example of images from the bone marrow lesion (BML) segmentation process. (a) Manually marked bone border on a typical
slice, (b) manually marked bone border on a slice near the edge of the bones, (c) the program’s segmentation of the bone, (d) the segmentation
results just based on thresholding, (e) the intermediate segmentation results with bone (red line) and BML (yellow line) by just using one time of
thresholding- curve evolution process, (f) the final image with bone (red line) and BML (yellow line) segmented.
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boundaries. To segment the BMLs we needed to prede-
fine two parameters (false discovery rate [FDR] [21] and
length penalty parameter [μ] [20]). The FDR is the
expectation of the ratio of false positives to all significant
hypotheses. We used the FDR to determine a threshold
between bright area and normal area within the bone
region. A greater FDR leads to a lower threshold and
therefore more pixels would be identified as a BML. The
length penalty parameter (μ; usually between 0 and 1)
was used to control the curvature of the segmented
BML boundaries. A greater μ leads to smoother thecurves and the more frequently relatively small areas of
discrete bright pixels would be eliminated. We set FDR
= 0.05 and μ = 0.28 in all of our experiments throughout
this paper. We tuned up FDR and μ based on the
consistency in the results of 10 pairs of knee data.
Based on the FDR, a rough segmentation was obtained
for the BMLs by a thresholding approach applied to the
MR images (Figure 1d). From the thresholded binary
image, we constructed initial curves of the BML boundaries
and then a region-based curve evolution method [20]
refined the initial curves to obtain an accurate BML border
(Figure 1e). In order to capture BMLs whose contrasts vary
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evolution process a second time while excluding the seg-
mented BMLs identified during the first curve evolution
step. Finally, we used the combination of those two BMLs
sets as the final BML volumes (Figure 1f). The volumetric
measurements of specific BMLs, based on this segmen-
tation approach, have been reported to have a good
correlation and agreement with manual measurements
of approximate BML volume [6].
The third step of this method, BML refinement and
quantification, automatically excluded false positive
regions (e.g., connective tissue, imaging artifacts) and
measure BML size. Currently we are using two criterions
to eliminate the false positive regions: (1) the distance
between a BML to the articular surface should be no
more than 10 mm [6,14,22] and (2) a BML should span
more than one MR image. Finally, we stacked the
processed 2-dimensional MR images into one 3D stack
data and used criterions above to exclude the false
positive regions and obtain the BML volumes. BML
volumes are calculated for four discrete regions: medial
femur, lateral femur, medial tibia, and lateral tibia.
Intra-tester and inter-tester reliability were assessed
for two investigators (JP and GD). To assess intra-tester
reliability the investigators segmented 10 (JP) or 12
(GD) knees (baseline and follow-up) from the progression
subcohort of the OAI (had symptomatic OA in at least
one knee). The investigators repeated their segmentations
at least 72 h after performing the initial segmentations.
After independently verifying their intra-rater reliability
they were provided a data set of 20 knees from the OAI
progression subcohort. Each investigator independently
segmented the knees. Intra-tester reliability for BML
change was good to excellent for investigator one (JP; ICC
[3,1 model] = 0.79 to > 0.99) and investigator two (GD;
ICC [3,1 model] = 0.95 to 0.96). Inter-tester reliability for
BML volume change was good for the lateral femur and
tibia as well as the medial femur (ICC [2,1 model] = 0.83
to 0.93) but low for the medial tibia BML volume change
(ICC [2,1 model] = 0.59).
Study 1: comparison to semi-quantitative BML size
We compared data generated by the semi-automated
BML segmentation method to Boston Leeds Osteoarthritis
Knee Scores (BLOKS) [10] for BMLs (semi-quantitative
grade 0 to 3) to assess the construct validity of the new
outcome measure. We selected a convenience sample of
80 right knees with area of denuded cartilage from a sub-
set of 160 participants that were members of the progres-
sion subcohort (had symptomatic OA in at least one knee)
and had acceptable quality fixed-flexion knee radiograph
and MR imaging sequences (identified as read project 4 in
the public OAI data files entitled kmri_qcart_ecksteinXX
[version 0.4 and 3.3]). This sample was convenient becausethere is extensive image assessment data publicly available
among these participants and BLOKS scores were
previously assessed by one investigator (GH; weighted
kappa = 0.88 [1]). We selected BLOKS scores, instead
of other BML scoring methods, based on our experience
with BLOKS scoring and prior research which indicated
that BLOKS was comparable with Whole Organ MR
Scoring (WORMS) method in cross-sectional studies [23].
One investigator (JP) performed the segmentation
using the new approach among 80 knees using OAI
baseline sagittal intermediate weighted, turbo spine
echo, fat-suppressed MR sequences [18]. The variables
of interest were medial and lateral tibia BML volume as
well as BLOKS BML scores in the medial and lateral
tibia. Analyses were restricted to the tibia since the
BLOKS system provides a score for the entire medial or
lateral tibia region, similar to the region of interest for
the segmentation method. Since only a small number of
BMLs were detected in the lateral tibia we collapsed
medial and lateral tibia for analyses and considered each
region to be independently assessed. Therefore, we
performed 3 Wilcoxon signed-rank tests to determine if
tibia BML volume was significantly different between
adjacent BLOKS BML scores (e.g., 1 versus 2, 2 versus 3).
Based on these analyses we reported the z statistics and
p-values with statistical significance defined as a p-value
≤ 0.05. We did not pursue ordinal logistic regression be-
cause the models had significant score test for the propor-
tional odds assumption.
Study 2: association between BML size and cartilage
morphology
We evaluated whether data from the new semi-automated
BML segmentation method would replicate findings from
previous studies that documented an association between
BMLs and cartilage parameters [6,10,24-26]. We selected a
convenience sample of 40 knees from 196 knees in the
baseline and 24-month OAI visit datasets (kmri_qcart_eck-
stein [version 0.4 and 3.3]) that had full thickness cartilage
loss on the tibia and femur in the index compartment
(defined as the tibiofemoral compartment with greater
denuded area). In order to have a heterogeneous sample, 20
knees were selected from the medial tibiofemoral index
compartment and 20 knees were selected from the lateral
tibiofemoral index compartment: knees that had the least
change in femur denuded area (n = 5), greatest change in
femur denuded area (n = 5), the least change in tibia
denuded area (n = 5), and greatest change in tibia denuded
area (n = 5). The sample size was selected based on the
strength of significant correlations we observed in our
previous study that explored an association between BML
volume and cartilage parameters (r = 0.48 to 0.63) [6].
One investigator (JP) performed the segmentation
using our new method on the 40 knees using baseline
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spine echo, fat-suppressed MR sequences. The variables
of interest were the change in tibia and femur BML volume
as well as change in tibia and central femur cartilage thick-
ness and denuded area. The central region of the femur
was defined as 60% of the distance between trochlear notch
and posterior edge of the femoral cartilage. All of the
analyses were limited to the index compartment. We
calculated Spearman correlation coefficients to assess
the relationship between 2-year BML volume change
and 2-year cartilage morphometry change. A significant
association was defined by a p-value ≤ 0.05. Potential
outliers were explored based on a 95% prediction
eclipse. We did not adjust these analyses since the goal
was to replicate previously reported associations be-
tween two measurements to determine the construct
validity of the new BML segmentation method.
Results
Comparison to semi-quantitative BML size
Among the 80 right knees 48 knees had BLOKS BML
scores. In the medial tibia, most knees had no to
medium size BMLs based on BLOKS: 11 (23%) knees
with BML = 0, 19 (40%) knees with BML = 1, 10 (21%)
knees with BML = 2, 8 (17%) knees with BML = 3. In
the lateral tibia, most knees had no to medium size
BMLs based on BLOKS: 25 (52%) knees with BML = 0,
13 (27%) knees with BML = 1, 4 (8%) knees with BML = 2,
6 (13%) knees with BML = 3. Figure 2 shows the distribu-
tion of tibia BML volume across BLOKS BML scores.
Overall, the tibial BML volume ranged from 0 mm3 to
3204.07 mm3 (only 2 knees had BML volume = 0 mm3).Figure 2 Box plots showing the distribution of tibia BML volume acro
contributed two regions (medial and lateral tibia) which were considered t
whiskers represent minimum and maximum medial tibia BML volume.BML volume was significantly greater among knees with
BLOKS BML score = 1 compared to knees with BLOKS
BML score = 0 (z = 2.85, p = 0.004), and among knees
with BLOKS BML scores = 2 compared to knees with
BLOKS BML score = 1 (z = 3.09, p = 0.002). There was no
significant difference between BLOKS BML scores 2 and 3
(z = −0.30, p = 0.77).
Association between BML size and cartilage morphology
We evaluated the association between 2-year change in
BML volume and change in cartilage morphometry
among 38 knees with denuded area (1 knee was
excluded because of poor image quality and another was
classified as having collapsed post avascular necrosis).
Table 1 provides an overview of the sample characteristics
for these analyses.
An increase in tibia BML volume was significantly related
to an increase in tibia denuded area (Spearman r = 0.42,
p = 0.008) and a decrease in tibia cartilage thickness
(Spearman r = −0.46, p = 0.004). Furthermore, increases
in tibia BML volume was associated with increased femur
denuded area (Spearman r = 0.35, p = 0.03) and possibly
decreased femur cartilage thickness (Spearman r = −0.30,
p = 0.07) but this last finding was not statistically signifi-
cant. No associations to femur BML volume change were
statistically significant (Spearman r = −0.15 to 0.15).
Discussion
In this manuscript we described the validity of a novel
semi-automated method to quantify BML size. This
method has several advantages compared to existing
methods. First, our method yields quantitative BMLss Boston Leeds Osteoarthritis Knee Scores (BLOKS). Each knee
o be independently assessed. Boxes represent interquartile range and
Table 1 Descriptive characteristics of knees used to
examine the association between Bone Marrow Lesion
(BML) size and cartilage morphology (n = 38)
Descriptive Characteristic Median (Min, Max)* or n (%)
Females 25 (66%)
OAI Progression Subcohort 36 (95%)
Radiographic Knee Osteoarthritis
(Kellgren-Lawrence Grade ≥ 2)
38 (100%)
Age (years, mean ± standard deviation) 61 ± 8
Body Mass Index (kg/m2; mean ±
standard deviation)
29.9 ± 5.3
Tibia BML Volume (baseline; mm3) 643.88 (17.97, 8120.29)
Femur BML Volume (baseline; mm3) 971.55 (21.79, 4205.43)
Tibia BML Volume Change (mm3) 86.22 (−5824.68, 3050.37)
Femur BML Volume Change (mm3) 164.41 (2268.4, 4634.04)
Tibia Cartilage Thickness Change (mm) −0.10 (−0.54, 0.19)
Central Femur Cartilage Change (mm) −0.18 (−0.96, 0.26)




* Median (Min, Max) reported instead of mean + standard deviation unless
noted otherwise.
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diameter [5], approximate BML volume [6,11]) or semi-
quantitative scoring methods (e.g., BLOKS [10], WORMS
[8]). Second, unlike manual segmentation methods [13,14]
our method does not require expert readers since the read-
er’s primary responsibility is to mark the border of the
bone, thus automating the BML segmentation step. There
are some other semi-automated methods [16,17] to quan-
tify BML volume, however their methods are based on
thresholding while our method performed some refinement
on thresholding results by eliminating small isolated bright
areas, as well as merging and evolving closed bright areas
(See Figure 1d and e). We found that the quantitative meas-
ure of BML volume increased across semi-quantitative
scoring and related to changes in cartilage thickness and
denuded area, confirming previous reports of this associ-
ation (construct validity).
Compared to BLOKS, the new measure of BML
volume increased across grades in the tibia, with the
exception of between grades 2 and 3. This suggests that
our approach yields consistent results with BLOKS scale
system in the evaluation of BMLs. The lack of statistical
significance between BLOKS BML scores 2 and 3 in the
medial tibia may be related to the available sample size
or the semi-quantitative nature of BLOKS BML scores
(e.g., potential for misclassifications). While some issues
arise from the semi-quantitative readings another issues
may be that the BML segmentation algorithm detects
any region of high signal intensity within the bone thatappears on multiple adjacent images (e.g., bone marrow
lesions, subchondral cysts, blood vessels). This limitation
led us to hypothesize that the BML segmentation
method should be used primarily for detecting longitudinal
change in BML volume since static structures will not
change over time. Since longitudinal studies of BML size
may be the main use of this program the next step was to
assess the construct validity of BML volume change.
Our second study agreed with previous reports that
change in BML size relates to longitudinal increases in
denuded area and decreased cartilage volume [5]. More
specifically, we found that increases in tibia BML volume
were related to tibia cartilage loss while no associations
were detected in the femur. The lack of association
between femur BML and femur cartilage loss may be
because the cartilage was assessing the central weight-
bearing region of the medial femur while the BMLs were
assessed throughout the medial femur (e.g., posterior
femoral condyle, trochlear region).
Based on these findings, the new semi-automated BML
segmentation method appears to be a valid assessment of
BML volume, particularly BML volume change. There are
several advantages of our method compared to existing
methods. Firstly, this new approach can accurately measure
volume rather than rough indices (e.g., greatest diame-
ter [5], approximate BML volume [6,11]). In addition to
improved accuracy, the semi-automated BML segmentation
method offers good intra-rater reliability and adequate
inter-rater reliability to allow for multiple raters if a quality
assessment step is in place to ensure consistent bone
segmentation. This extra quality assessment procedure is
not uncommon in other areas of knee segmentation [27]. It
is important to note that raters only mark the edges of the
bone and therefore raters are not responsible for adjusting
the contrast or identifying the boundary of a region that is
not well delineated. The boundary of unclear BMLs would
be located by the active contour driven by pixel intensity
distribution automatically. Our approach should be more
consistent than prior methods because it segments the
BMLs from the bone region directly based on the intensity
of the MR images without doing any preprocessing.
In addition to good reliability, our approach is a very
time efficient method to quantify the BMLs. The current
approach requires about 4 to 12 min for raters to
initially segment the bones, depending on the number of
images. The major reason for improved time efficiency
is the reduction of manual operation. Only the first step
needs manual operation and the remaining two steps are
fully automated and take about 4 to 5 min using Matlab
code on a personal computer with an Intel Core
2.66 GHz CPU and 2.0 GB RAM. Moreover, bone
boundaries have distinct patterns and are less subjective
to segment than BMLs. Based on the inter-rater and
intra-rater reliability as well as the reduced manual
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more efficiently investigate larger MR imaging data sets.
While the new semi-automated BML segmentation
method has many advantages that make it appealing for
implementation there are some limitation and opportun-
ities for improvement. Once the bone initialization (the first
step) is finished, various algorithms could be proposed to
perform bone segmentation and BML segmentation which
might be faster and yield more robust and consistent
results. For example, the current algorithm for BML
segmentation only uses the mean and standard deviation
of the pixel intensity in the MR images, but some other
statistical variables of the intensities or even location infor-
mation of BMLs could be incorporated to improve the
segmentation results. In addition, once the segmentation
of the bone and the BMLs is finished in a larger data set,
other features of BMLs can be investigated besides BML
volume. For example, users could extract the distance,
intensity distribution, or other features of the BMLs.
Moreover, the current algorithm for bone segmentation
could be improved by more advanced algorithms. Those
more advanced algorithms could further reduce or even
omit manual operation which would make our approach
more efficient and robust.
Optimizing the algorithms may improve the segmenta-
tion results in the central region of the knee, which was
excluded in these analyses, as well as help differentiate
BMLs and subchondral cysts. This region was omitted
because of technical challenges in accurately identifying
the border of the bone and increased signal-intensity
heterogeneity. Excluding this region may bias the BML
results by under representing BMLs associated with
patellofemoral joint changes but may be advantageous
for evaluating the tibiofemoral joint. Previous research
has suggested that centrally-located BMLs do not
typically influence tibiofemoral cartilage unless they
extend into the medial tibiofemoral compartment [28].
New algorithms may also lead to the ability to discriminate
BMLs and subchondral cysts, which could facilitate studies
that clarify the etiology of both lesions and how they
change over time. In the current analyses, we considered
BMLs and subchondral cysts as one classification of
subchondral changes since subchondral cysts often
develop in regions with BMLs [29,30] and both types of
lesions are associated with pain and structural changes
[1-7,31,32]. When interpreting results with this BML
segmentation method it is important to consider that
these results primarily reflect tibiofemoral BMLs that
may include cystic changes.
While these validation studies demonstrated the validity
of the new semi-automated BML segmentation methods
there are some important limitations to these analyses.
For example, we compared the new BML volume to
BLOKS, a well validated measure of BML size but BLOKSis not a gold standard and does not offer a quantitative
comparison. Ideally, the new BML volume would have
been compared to another accurate quantitative outcome
or histology but these methods also introduce various
limitations (e.g., lack of agreement on the histological
presentation of BMLs, lack of gold standard quantitative
BML measures). Furthermore, the validation studies were
all conducted using sagittal intermediate weighted turbo
spin echo with fat suppression images collected at the four
OAI clinical sites using 3 T Siemens scanners. The BML
segmentation approach may need to be reevaluated when
deployed in new data sets using different MR scanners,
MR sequences, or study populations (e.g., knees without
full thickness cartilage loss). The limited generalizability of
these validation studies does not limit the usefulness of
this new method particularly because any new method
would also need to be reevaluated when deployed in a
new study protocol or population.
Conclusions
In summary, we proposed a novel semi-automated
method to quantify BML sizes. We validated our new
method by demonstrating that the new BML volume
measurement increases with greater BLOKS BML scores
and confirming previous reports that BML size is asso-
ciated with longitudinal cartilage loss among knees with
full thickness cartilage loss. In addition, our method is
time efficient (about 7 min per knee MR scan) and yields
adequate intra- and inter-rater reliability to allow multiple
raters to process the MR sequences if an additional quality
assessment step is performed to help ensure consistency
between raters. This new method will enable researchers
to assess larger MR data sets in a time efficient manner.
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